These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5699093)

  • 21. Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias.
    Raper C; Wale J
    Eur J Pharmacol; 1968 Aug; 4(1):1-12. PubMed ID: 5680367
    [No Abstract]   [Full Text] [Related]  

  • 22. Some cardiac effects of 1-allyl-2-benzyl-piperidine hc1, in vitro and in vivo.
    Ferko AP
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):363-75. PubMed ID: 5012446
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of various antiarrhythmic drugs on the daunomycin-induced arrhythmia in the hamster.
    Herman EH; Schein P; Taylor O; Waravdekar VS
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):69-72. PubMed ID: 5412364
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the effects of pronethalol, MJ 1999, D(-) INPEA and L(+) INPEA on the pressor response to acethycholine in atropinized dogs.
    Abiko Y; Minamidate A; Ito M
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):130-6. PubMed ID: 4390661
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.
    Farmer JB; Levy GP
    Br J Pharmacol; 1968 Sep; 34(1):116-26. PubMed ID: 5676002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.
    Lish PM; Shelanski MV; LaBudde JA; Williams WR
    Curr Ther Res Clin Exp; 1967 Jun; 9(6):311-24. PubMed ID: 4963067
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol.
    Aberg G; Dzedin T; Lundholm L; Olsson L; Svedmyr N
    Life Sci; 1969 Apr; 8(7):353-65. PubMed ID: 5769443
    [No Abstract]   [Full Text] [Related]  

  • 28. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.
    Singh BN; Vaughan Williams EM
    Br J Pharmacol; 1970 Aug; 39(4):675-87. PubMed ID: 5485144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiarrhythmic properties of 3-(2-hydroxy-3 isopropylamino-propoxy)-3 phenyl-2 isoindolinone-1, (RS, SR) in the dog].
    Detaille JY; Caillard CG; Mondot S; Louis JC; Julou L
    C R Seances Acad Sci D; 1979 Feb; 288(5):555-8. PubMed ID: 108025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathomimetic action of an adrenergic beta receptor blocking agent, 4-(2-isopropylamino-1-hydroxyethyl) methanesulphonanilid hydrochloride (MJ1999).
    Agarwal SL; Bose D; Natu MV; Gandhi IS
    Indian J Med Res; 1968 Feb; 56(2):227-33. PubMed ID: 5657521
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic activity of some isoquinoline derivatives determined by a rapid screening procedure in the mouse.
    Lawson JW
    J Pharmacol Exp Ther; 1968 Mar; 160(1):22-31. PubMed ID: 4966361
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.
    Fitzgerald JD; Scales B
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):467-74. PubMed ID: 5718774
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative action of propranolol and sotalol (MJ-1999) on myocardial oxygen consumption in dogs: hemodynamic correlates.
    Levy JV
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):114-9. PubMed ID: 4391634
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of the protective effect of dalargin on development of ischemic heart arrhythmias].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Semushkina TM
    Biull Eksp Biol Med; 1996 Aug; 122(8):176-8. PubMed ID: 9081471
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of dextro and laevo rotatory isomers of H 56-28 on experimental ventricular arrhythmias.
    Madan BR; Mishra SN; Khanna VK
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):121-9. PubMed ID: 5365227
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 37. Antagonism to ouabain induced ventricular fibrillation; action of reserpine, propranolol, INPEA and quinidine.
    Bagchi N; Arora RB; Singh M
    Jpn J Pharmacol; 1969 Dec; 19(4):620-1. PubMed ID: 5308407
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen EKUE JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 5564246
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
    Lynch JJ; Wilber DJ; Montgomery DG; Hsieh TM; Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(6):1132-41. PubMed ID: 6084771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the antiarrhythmic effects of PA related to wavelength?
    Tribulova N; Manoach M
    Circulation; 1999 Apr; 99(16):2220-1. PubMed ID: 10217701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.